✦ LIBER ✦

Mortality in nonalcoholic fatty liver disease: Clues from the cremona study

✍ Scribed by Leon A. Adams

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 71 KB
Volume: 54
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.24445

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fatty liver index and mortality: The cre

Fatty liver index and mortality: The cremona study in the 15th year of follow-up

✍ Giliola Calori; Guido Lattuada; Francesca Ragogna; Maria Paola Garancini; Paolo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 1 views

A fatty liver, which is a common feature in insulin-resistant states, can lead to chronic liver disease. It has been hypothesized that a fatty liver can also increase the rates of non-hepaticrelated morbidity and mortality. Therefore, we wanted to determine whether the fatty liver index (FLI), a sur

Long-term mortality in nonalcoholic fatt

Long-term mortality in nonalcoholic fatty liver disease: Is liver histology of any prognostic significance?

✍ Paul Angulo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 1 views

Corrections: Long-term mortality in nona

Corrections: Long-term mortality in nonalcoholic fatty liver disease: Is liver histology of any prognostic significance?

✍ Paul Angulo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB 👁 1 views

Data describing cirrhosis prevalence in the simple steatosis group reported in the study by Rafiq et al. should read NR (not reported) instead of 42 (56.8%). All cirrhosis prevalence proportions were calculated based upon these correct (NR) data.

Nonalcoholic fatty liver disease: is it

Nonalcoholic fatty liver disease: is it all in the genes?

✍ Dawn McDowell Torres; Stephen A. Harrison 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 292 KB 👁 1 views

Background: Patients with cirrhosis in Child-Pugh class C or those in class B who have persistent bleeding at endoscopy are at high risk for treatment failure and a poor prognosis, even if they have undergone rescue treatment with a transjugular intrahepatic portosystemic shunt (TIPS). This study ev

Progress in understanding the pathogenes

Progress in understanding the pathogenesis of nonalcoholic fatty liver disease

✍ Richard H. Moseley 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB 👁 2 views

The pathogenesis of nonalcoholic steatohepatitis (NASH) is poorly defined. Feeding mice a diet deficient in methionine and choline (MCD diet) induces experimental NASH. Osteopontin (OPN) is a Th1 cytokine that plays an important role in several fibroinflammatory diseases. We examined the role of OPN

A genomic and proteomic study of the spe

A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease

✍ Zobair M. Younossi; Ancha Baranova; Katharine Ziegler; Luca Del Giacco; Karen Sc 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 1 views

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, and some of its forms are progressive. This study describes the profiling of hepatic gene expression and serum protein content in patients with different subtypes of NAFLD. Liver biopsy specimens from 98 bariatric sur